WEBULL
News
BHC
5.99
+2.57%
0.15
DIARY-Canada corporate earnings week ahead
Reuters · 13h ago
Is Bausch Health (BHC) Turning Social Media Buzz And Deleveraging Efforts Into A Credible Turnaround Narrative?
Simply Wall St · 2d ago
Reassessing Bausch Health Companies (BHC) Valuation After Recent Share Price Swings
Simply Wall St · 4d ago
Weekly Report: what happened at BHC last week (0202-0206)?
Weekly Report · 4d ago
Is Bausch Health (BHC) Pricing Reflect Long Term Potential After 81% Five Year Share Slump
Simply Wall St · 5d ago
Xifaxan Trial Setback Puts Bausch Health Growth Plans Under Review
Simply Wall St · 02/06 22:10
Xifaxan Trial Failure Raises Questions Around Bausch Health Patent Cliff
Simply Wall St · 02/05 00:53
Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention
NASDAQ · 02/04 04:20
Attorney General James Secures More Than $17M from Drug Manufacturers Bausch And Lannett For Conspiracy To Inflate Prices
Benzinga · 02/02 19:45
NY AG announces settlement with Lannett and Bausch Health
TipRanks · 02/02 19:40
Weekly Report: what happened at BHC last week (0126-0130)?
Weekly Report · 02/02 10:28
A Look At Bausch Health (BHC) Valuation After RED-C Phase 3 Trial Setback
Simply Wall St · 02/01 11:16
Phase 3 RED-C Miss for Hepatic Encephalopathy Prevention Might Change The Case For Investing In Bausch Health Companies (BHC)
Simply Wall St · 01/31 02:26
*Moody's Ratings Completes Review of Bausch With Caa2 Corporate Family Rating
Dow Jones · 01/27 17:22
*Moody's Ratings: Stable Outlook Reflects Company's High Leverage With Generic Exposures Facing Xifaxan, Bausch's Largest Product
Dow Jones · 01/27 17:22
*Moody's Ratings: Planning Separation of Bausch + Lomb Would Increase Business Risks
Dow Jones · 01/27 17:22
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Revolution Medicines (RVMD) and Bausch Health Companies (BHC)
TipRanks · 01/27 12:31
AllianceBernstein Global High Income Fund Inc. Reports December 31 NAV of $11.43
Reuters · 01/26 21:06
Weekly Report: what happened at BHC last week (0119-0123)?
Weekly Report · 01/26 10:28
More
Webull provides a variety of real-time BHC stock news. You can receive the latest news about Bausch Health Companies Inc through multiple platforms. This information may help you make smarter investment decisions.
About BHC
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.